Federal Supply Schedule 36F79721D0196
Award Date
8/1/21
Last Date to Order
7/31/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Myovant Sciences Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Vantive US Healthcare LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Federal Supply Schedule 65 IB. With a potential value of $25,000 and a period of performance through August 2024, this multiple-award schedule aims to ensure Veterans receive needed medical supplies and treatments. The...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Aytu Biopharma Inc. for pharmaceuticals and drugs under GSA Schedule 65 IB. With a potential value of $2,942,740 and a period of performance through August 1, 2023, this multiple-award contract provides various pharmaceutical products and hematology-related items to VA medical facilities. The original solicitation sought drugs,...
The federal supply schedule contract provides pharmaceuticals and drugs under GSA schedule 65 IB. Awarded by the Department of Veterans Affairs Veterans Health Administration VISN 12, the multiple award contract has a potential value of $225,000. Nnodum Pharmaceuticals Corporation, an 8A certified small disadvantaged minority-owned business, is the prime contractor. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for the VA to support veterans' healthcare...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to TG Therapeutics Inc. The contract provides pharmaceuticals and drugs under GSA Schedule 65 IB, which covers drugs, pharmaceuticals, and hematology related products. With a potential value of $20 million and a period of performance through August 2026, this multiple-award contract aims to procure these medical supplies for VA healthcare...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Natures Sources LLC. The contract provides pharmaceuticals and drugs under GSA Schedule 65 IB, with a potential value of $427,500. The period of performance is July 1, 2020 through June 30, 2025. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for the VA network. As a multiple-award schedule, it...
The Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Nextgen Pharmaceuticals LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. With a potential value of $400,000 and a period of performance through July 2028, the multiple award contract aims to meet the healthcare needs of veterans through the procurement of pharmaceuticals and...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Civicascript LLC, a non-profit limited liability company. The contract, valued at a ceiling of $225,000.00, is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA and has a period of performance through August 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows ordering from...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Immunomedics, Inc. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master GSA Schedule, with a potential value of $10,000,000. The period of performance is January 1, 2021 through December 31, 2025. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for the VA network through task...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Urovant Sciences Inc., a subsidiary of Sumitovant Biopharma, Inc. This multiple-award contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS-61-IB. The contract has a potential value of $700,000.00 and a period of performance through September 14, 2026. The contract aims to provide the Department...
This multiple award IDV was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to acquire pharmaceuticals and drugs under GSA's Pharmaceuticals and Drugs Schedule. The contract aims to procure a range of drugs, pharmaceuticals, and hematology-related products for $225,000 over its June 2021 to December 2021 period of performance. Oncopeptides, Inc. is the prime contractor tasked with delivering these products and services under...